AliyaliMPoorhasan AmiriASharifpoorAZalliF
When comes to its half-life it is nearly one week
As new therapies emerge, having access to experienced providers who stay ahead of the science matters
The standard applied here is simple: nothing goes in the capsule that would not be there if manufacturing cost were not a consideration
Age-related sarcopenia, hormone decline, and GLP-1-induced weight loss create a triple threat to lean mass
Our program includes injectable and oral GLP-1 options including semaglutide, also known as Ozempic/Wegovy, tirzepatide, also known as Mounjaro/Zepbound, retatrutide and orforglipron, also known as Foundayo, when clinically appropriate